| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0005 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0006 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0006 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0006 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0006 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0006 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0006 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.2 | 0.0007 |